HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.

Abstract
The response of the colon to aldosterone is believed to be an important adaptive mechanism to excessive sodium losses in diarrhea. However, the degree to which mineralocorticoid activity actually influences fecal output of sodium in people with diarrhea is unknown. To gain insight into this question, 10 normal people were treated with placebo, fludrocortisone (an aldosterone agonist), and spironolactone (an aldosterone antagonist) during three experimental periods lasting nine days. On days 5-8, diarrhea was induced by ingestion of phenolphthalein. Diet was controlled. Fecal sodium was 40 meq/day on placebo and 29 meq/day on fludrocortisone, consistent with mineralocorticoid stimulation of intestinal sodium absorption. However, contrary to our expectations, spironolactone therapy was also associated with a fall in fecal sodium output, to 28 meq/day. To explain this paradoxical effect of spironolactone, we suggest that sodium depletion caused by spironolactone's natriuretic action on the kidney caused the release of an unknown stimulant of intestinal sodium absorption, whose action more than overcame the reduced colonic absorption resulting from inhibition of aldosterone activity by spironolactone. This interpretation implies that the intestinal adaptation to sodium depletion in diarrhea involves both aldosterone and an aldosterone independent factor, working in concert to reduce fecal sodium output.
AuthorsH H Wenzl, K D Fine, C A Santa Ana, J L Porter, J S Fordtran
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 42 Issue 1 Pg. 119-28 (Jan 1997) ISSN: 0163-2116 [Print] United States
PMID9009126 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cathartics
  • Electrolytes
  • Mineralocorticoid Receptor Antagonists
  • Mineralocorticoids
  • Phenolphthaleins
  • Serum Albumin
  • Water
  • Spironolactone
  • Aldosterone
  • Phenolphthalein
  • Sodium
  • Renin
  • Potassium
  • Fludrocortisone
Topics
  • Adult
  • Aldosterone (blood)
  • Body Weight
  • Cathartics
  • Diarrhea (chemically induced, metabolism)
  • Electrolytes (blood)
  • Feces (chemistry)
  • Female
  • Fludrocortisone (pharmacology)
  • Humans
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists (pharmacology)
  • Mineralocorticoids (agonists, antagonists & inhibitors, pharmacology, physiology)
  • Phenolphthalein
  • Phenolphthaleins
  • Potassium (metabolism)
  • Renin (blood)
  • Serum Albumin (analysis)
  • Sodium (metabolism)
  • Spironolactone (pharmacology)
  • Water (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: